OBSTRUKTİF UYKU APNE SENDROMU'NDA İNFLAMASYON

Yıl 2015, Cilt: 29 Sayı: 1, 1 - 9, 01.05.2015

Emel Bulcun Mehmet Ekici Üçler Kısa Aydanur Ekici

Öz

Amaç: Obstruktif uyku apne sendromu (OUAS) ve inflamasyon arasındaki ilişki tartışmalıdır. Uyku apne ve obesite farklı mekanizmalarla inflamasyonu arttırabilir. Bu çalışma uyku apnesi ve obesite ile proinflamatuar durumun ilişkisini inceledi. Metod: Toplam 133 olguya polisomnografi yapıldı. Polisomnografileri yapılarak, apne hipopne indeksi (AHI)>5 olan 112 OUAS tanılı hasta ve AHI5 olan 21 kontrol grubu birey çalışmaya dahil edildi. Kontrol grubu bireyler grup A olarak kabul edildi. Bununla birlikte OUAS tanılı hastalar VKİ’lerine göre non-obese grup (B grup) (VKİ<30) ve obese grup
(C grup) (VKİ>30) olarak iki gruba ayrıldı. Bulgular: Tüm inflamatuar sitokinler (CRP, hs CRP, TNF-ά, IL-6) obez uyku apneli hastalarda kontrol grubu bireylerden anlamlı olarak daha yüksekti. İnsülin rezistansı obez uyku apneli hastalarda obez olmayan hastalardan ve kontrol grubundan daha yüksekti fakat insülin rezistansı kontrol grubu ve obez olmayan uyku apneli hastalar arasında farklı değildi. Tüm inflamatuar sitokinler pearson korelasyon analizinde VKİ ile anlamlı ilişki gösterdi. Ancak multiple varians analizinde CRP, hs CRP VKİ
ile anlamlı ilişkiliyken, TNF-ά, IL-6’nın VKİ ile anlamlı ilişkisi yoktu. Tüm inflamatuar sitokinler
yine bu analize göre desaturasyon indeksi ile anlamlı ilişkiliydi. Sonuç: Adipöz dokunun proinflamatuar durumun gelişiminde anahtar rol oynadığı için bu hastalarda obesite hem uyku apnesinin şiddetini arttırır hem de inflamasyonun artışını tetikler. OSAS’ın ve metabolik bozuklukların erken tespiti kardiovasküler morbidite ve mortalitenin azalmasına yardımcı
olur.

Anahtar Kelimeler

Obstruktif uyku apne sendromu, İnflamasyon, Obesite, İnsülin rezistansı

THE INFLAMMATION IN OBSTRUCTIVE SLEEP APNEA SYNDROME

Öz

Aim: The association between obstructive sleep apnea syndrome (OSAS) and inflammation remains controversial. This study investigated the relationship between OSAS and obesity with proinflammatory state. Method: A total of 133 consecutive subjects who were referred for polysomnography. 112 were documented to have OSAS defined as AHI >5 and 21 control subjects with AHI<5 were selected
upon polysomnography. Control group has been accepted as A group. In addition, patients with OSAS were divided into the following two groups based on the BMI as non-obese (B group) (BMI <30) and obese (C group) (BMI>30). Result: CRP, hs CRP, TNF-ά, IL-6 were significantly higher in the obese patients with OSAS than in the control group. Insulin resistance was higher in obese patients with sleep apnea than both in nonobese
patients and control group but insulin resistance did not differ between control group
and non-obese patients with sleep apnea. All of inflammatory cytokines showed significant
associations with BMI in pearson correlation analysis. However, in multiple variance analysis, CRP, hs CRP were significant associated with BMI while TNF-ά, IL-6 were not significant associated BMI. All of inflamatory cytokines were significantly
associated with desaturation index according to this analysis. Conclusion: Obesity increases both severity of sleep apnea and causes aggravate of inflammation
in these patients because adipose tissue play a key role for the development of the proinflammatory state. Early detection of OSAS and metabolic dysfunction may help to decrease the cardiovascular morbidity and mortality.

Anahtar Kelimeler

Obstructive Sleep Apnea Syndrome, Inflammation, Obesity, Insulin Resistance

Kaynakça

• 1. Marshall NS, Wong KK, Phillips CL et al. Is Sleep Apnea an Independent Risk Factor for Prevalent and Incident Diabetes in the Busselton Health Study?. Clin Sleep Med. 2009; 15: 15-20.
• 2. Babu AR, Herdegen J, Fogelfeld L et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005; 165: 447-52.
• 3. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133: 496-506.
• 4. Louis M, Punjabi N. M Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009, 106: 1538-44.
• 5. Coughlin S, Calverley P, Wilding J: Sleep disordered breathing-a new component of syndrome x? Obes Rev 2001; 2: 267-74.
• 6. Tkacova, R, Rizzo M, Berneis K. Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype. Med Hypotheses 2009; 73: 441-4.
• 7. Skarfors ET, Selinus I, Lithell HO. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 1991; 303: 755-60.
• 8. Leinum CJ, Dopp JM, Morgan BJ. Sleepdisordered breathing and obesity: pathophysiology, complications, and treatment. Nutr Clin Pract. 2009; 24: 675-87.
• 9. Lévy P, Bonsignore MR, Eckel J. Sleep, sleepdisordered breathing and metabolic consequences. Eur Respir J. 2009; 34: 243-60.
• 10. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28 :412-9.
• 11. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, 2 nd ed: Diagnostic and Coding Manual, American Academy of Sleep Medicine, Westchester, IL 2005.
• 12. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14: 540-5.
• 13. Vgontzas AN, Papanicolaou DA, Bixler EO et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J. Clin Endocrinol Metab. 2000; 85: 1151-8.
• 14. Punjabi NM, Shahar E, Redline S et al. Sleepdisordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol 2004; 160: 521-30.
• 15. Peled N, Kassirer M, Shitrit D et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respiratory Medicine 2007; 101: 1696-701.
• 16. McArdle N, Hillman D, Beilin L et al. Metabolic Risk Factors for Vascular Disease in Obstructive Sleep Apnea A Matched Controlled Study. Am J Respir Crit Care Med. 2007; 175: 190-5.
• 17. Kono M, Tatsumi K, Saibara T et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-92.
• 18. Punjabi NM, Sorkın JD, Katzel LI et al. Sleepdisordered Breathing and Insulin Resistance in Middle-aged and Overweight Men. Am J Respir Crit Care Med 2002; 165: 677–82.
• 19. Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med. 1996; 154: 170–4.
• 20. Gruber A, Horwood F, Sithole J et al. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol. 2006; 5: 22.
• 21. Ip MS, Lam B, Ng MM et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002; 165: 670-6.
• 22. Bastard JP, Maachi M, Lagathu C et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006; 17: 4-12.
• 23. Torres-Leal FL, Fonseca-Alaniz MH, Rogero MM et al. The role of inflamed adipose tissue in the insulin resistance. Cell Biochem Funct. 2010; 28: 623-31.
• 24. Sheu WH, Chang TM, Lee WJ et al. Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity 2008; 16: 1033-8.
• 25. Iiyori N, Alonso LC, Sanders MH et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007; 175: 851-7.
• 26. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol. 2009; 106: 1538-44.
• 27. Brooks B, Cistulli PA, Borkman M et al. Obstructive sleep apnea in obese noninsulindependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J. Clin Endocrinol Metab. 1994; 79: 1681-5.